Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 19 Show results per page	View Search Criteria \| Help With Results

Last Modified: 7/13/2007 First Published: 1/1/1998


1.		Phase II Study of Whole Body Hyperthermia Combined With Doxorubicin HCl Liposome and Fluorouracil in Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				UTHSC-MS-96205 NCI-V97-1356, NCT00003135

Last Modified: 8/29/2008 First Published: 10/25/2003


2.		Phase II Randomized Study of Tariquidar and Docetaxel in Patients With Recurrent or Metastatic Lung, Ovarian, Cervical Cancer, or Renal Cell Carcinoma (no longer accruing patients with ovarian or lung cancer as of 3/01/06)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				NCI-03-C-0284 NCT00072202

Last Modified: 8/12/2008 First Published: 8/24/2005


3.		Phase II Study of Isotretinoin, Interferon alfa-2b, and Paclitaxel in Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Over 18				Other				CINJ-100101 CINJ-3390, CINJ-NJ1703, NCT00138151


4.		Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				UCI 03-33 NCT00257816


5.		Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				VEG105281 NCT00430781

Last Modified: 5/22/2008 First Published: 5/4/2007


6.		Phase II Pilot Study of Irradiated Allogeneic Related Donor Lymphocyte Infusion in Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Any age				NCI				CINJ-3330 NCT00161187


7.		Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				06-1098 GSK 107278, NCT00548418


8.		Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				04-061 NCT00587964


9.		Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Not specified				Other				2007-0324 NCT00626561

Last Modified: 9/19/2008 First Published: 6/3/2008


10.		Phase II Study of Pemetrexed Disodium and Cisplatin in Patients With Advanced, Persistent, or Recurrent Carcinoma of the Cervix

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Not specified				NCI				GOG-0076GG GOG-0076GG, NCT00691301

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute